R Dahl

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. ncbi Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
    R Dahl
    University Hospital Aarhus, Department of Respiratory Diseases, Aarhus, Denmark
    Am J Respir Crit Care Med 164:778-84. 2001
  2. ncbi Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma
    R Dahl
    Aarhus Kommunehospital, Aarhus, Denmark
    Respiration 71:126-33. 2004
  3. ncbi Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function
    L P Nielsen
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Am J Respir Crit Care Med 162:2053-7. 2000
  4. ncbi Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics
    L P Nielsen
    Department of Respiratory Diseases, Aarhus University Hospital, Copenhagen, Denmark
    Respir Med 93:863-8. 1999
  5. ncbi Regulated exocytosis in immune function: are SNARE-proteins involved?
    A Shukla
    Department of Respiratory Diseases, Aarhus University Hospital, Denmark
    Respir Med 94:10-7. 2000
  6. doi Cultured mast cells from patients with asthma and controls respond with similar sensitivity to recombinant Der p2-induced, IgE-mediated activation
    I K Krohn
    Department of Pulmonary Medicine, Aarhus University Hospital, Aarhus, Denmark
    Scand J Immunol 78:352-6. 2013
  7. ncbi Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma
    R Dahl
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Allergy 60:875-81. 2005
  8. ncbi Effect of ciclesonide on allergen challenge in subjects with bronchial asthma
    B B Larsen
    University Hospital Aarhus, Aarhus, Denmark
    Allergy 58:207-12. 2003
  9. ncbi Mode of action of intranasal corticosteroids
    N Mygind
    Department of Respiratory Diseases, Aarhus University Hospital, Denmark
    J Allergy Clin Immunol 108:S16-25. 2001
  10. ncbi Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction
    R Dahl
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Respir Med 97:1126-33. 2003

Collaborators

Detail Information

Publications15

  1. ncbi Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
    R Dahl
    University Hospital Aarhus, Department of Respiratory Diseases, Aarhus, Denmark
    Am J Respir Crit Care Med 164:778-84. 2001
    ..We conclude that formoterol is more effective than ipratropium bromide in the treatment of COPD, as the efficacy of ipratropium on airflow obstruction does not translate into a clinical benefit that patients can perceive...
  2. ncbi Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma
    R Dahl
    Aarhus Kommunehospital, Aarhus, Denmark
    Respiration 71:126-33. 2004
    ..Conclusion: Delivery of formoterol via the Certihaler or Aerolizer combines rapid relief with enduring control and provides convenient bronchodilation in patients with persistent asthma...
  3. ncbi Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function
    L P Nielsen
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Am J Respir Crit Care Med 162:2053-7. 2000
    ..Therapeutic ratio over a wide dose range, determined by impact on bronchial responsiveness and endogenous corticosteroid production, seems to favor FP...
  4. ncbi Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics
    L P Nielsen
    Department of Respiratory Diseases, Aarhus University Hospital, Copenhagen, Denmark
    Respir Med 93:863-8. 1999
    ..05 for both). The results demonstrate, that the addition of salmeterol to corticosteroid treatment offers a clinically relevant potential for reduction of inhaled corticosteroid dose in steroid sensitive asthmatics...
  5. ncbi Regulated exocytosis in immune function: are SNARE-proteins involved?
    A Shukla
    Department of Respiratory Diseases, Aarhus University Hospital, Denmark
    Respir Med 94:10-7. 2000
    ..This review is a brief summary of these proteins and it includes recent results from studies on regulated exocytosis in inflammatory cells...
  6. doi Cultured mast cells from patients with asthma and controls respond with similar sensitivity to recombinant Der p2-induced, IgE-mediated activation
    I K Krohn
    Department of Pulmonary Medicine, Aarhus University Hospital, Aarhus, Denmark
    Scand J Immunol 78:352-6. 2013
    ..Activation of cultured mast cells appears to depend on culture conditions (IL-4, IgE) rather than on donor status as atopy and asthma...
  7. ncbi Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma
    R Dahl
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Allergy 60:875-81. 2005
    ..We investigated the effect of intranasal, inhaled corticosteroid or the combination of both in patients with both pollen-induced rhinitis and asthma...
  8. ncbi Effect of ciclesonide on allergen challenge in subjects with bronchial asthma
    B B Larsen
    University Hospital Aarhus, Aarhus, Denmark
    Allergy 58:207-12. 2003
    ..Also, this study provides further data on safety and tolerance of ciclesonide...
  9. ncbi Mode of action of intranasal corticosteroids
    N Mygind
    Department of Respiratory Diseases, Aarhus University Hospital, Denmark
    J Allergy Clin Immunol 108:S16-25. 2001
    ..Studies should be conducted to characterize the broad range of mechanisms by which INCS produce their therapeutic effects in allergic rhinitis...
  10. ncbi Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction
    R Dahl
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Respir Med 97:1126-33. 2003
    ..In summary, use of the HandiHaler can be easily taught with fewer errors compared to the MDI. Furthermore, patient performance using the HandiHaler was superior to that with an MDI despite prior MDI experience and more frequent usage...
  11. ncbi Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms
    R Dahl
    Department of Respiratory Diseases, University Hospital of Aarhus, Denmark
    Respir Med 96:432-8. 2002
    ..Maintenance treatment with inhaled budesonide gave a dose-related reduction in airways obstruction, bronchial reactivity and asthma symptom severity. The efficacy of inhaled corticosteroid was superior to oral theophylline...
  12. ncbi Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis
    R Dahl
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Allergy 61:185-90. 2006
    ..As rhinoconjunctivitis often co-exists with asthma, we aimed to confirm safety and efficacy in grass allergic subjects with asthma and rhinoconjunctivitis...
  13. doi Serum eosinophil granule proteins predict asthma risk in allergic rhinitis
    L P Nielsen
    Departments of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Allergy 64:733-7. 2009
    ..It is important to characterize these patients, thereby offering the possibility for prevention. This study evaluated eosinophil parameters as potential indicators of deteriorating allergic airway disease...
  14. pmc SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma
    G Blumberga
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus C, Denmark
    Allergy 66:178-85. 2011
    ..The immunomodulatory ability of SQ-standardized house dust mite (HDM) subcutaneous immunotherapy (SCIT) was investigated in patients with allergic asthma...
  15. ncbi Nebulized terbutaline and positive expiratory pressure in chronic obstructive pulmonary disease
    E F Christensen
    Department of Respiratory Diseases, University Hospital of Aarhus, Denmark
    Pneumologie 45:105-9. 1991
    ..PEP alone gave the least increase in PEF (25 1/min), and there was no difference between the increase in PEF after terbutaline inhaled with PEP (28 1/min) compared to terbutaline alone (29 1/min)...